Vitalhub Corp. (TSX:VHI)

ASLAN Pharmaceuticals Revenue

Vitalhub had revenue of 21.67M CAD in the quarter ending March 31, 2025, with 42.07% growth. This brings the company's revenue in the last twelve months to 75.01M, up 35.97% year-over-year. In the year 2024, Vitalhub had annual revenue of 68.59M with 30.64% growth.

• Revenue (ttm): 75.01M
• Revenue Growth: +35.97%
• P/S Ratio: 10.20
• Revenue / Employee: 150.02K
• Employees: 500
• Market Cap: 765.45M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	68.59M	16.09M	30.64%
Dec 31, 2023	52.51M	12.54M	31.37%
Dec 31, 2022	39.97M	15.31M	62.06%
Dec 31, 2021	24.66M	10.87M	78.80%
Dec 31, 2020	13.79M	3.57M	34.87%